Asia Pacific Pharmaceutical announced that the company first implemented a share repurchase on August 11, 2026, and has completed the repurchase. This time, 3.344,500 shares were repurchased, accounting for 0.45% of the total share capital. The highest transaction price was 6.03 yuan/share, the lowest transaction price was 5.91 yuan/share, and the total transaction amount was 19998,000 yuan. The repurchase is in line with the established plan and will not have a significant impact on the company's operations, etc. The repurchased shares will be stored in a special account to implement equity incentives or employee stock ownership plans. If not used within three years, they will be cancelled according to law.

Asia Pacific Pharmaceutical announced that the company first implemented a share repurchase on August 11, 2026, and has completed the repurchase. This time, 3.344,500 shares were repurchased, accounting for 0.45% of the total share capital. The highest transaction price was 6.03 yuan/share, the lowest transaction price was 5.91 yuan/share, and the total transaction amount was 19998,000 yuan. The repurchase is in line with the established plan and will not have a significant impact on the company's operations, etc. The repurchased shares will be stored in a special account to implement equity incentives or employee stock ownership plans. If not used within three years, they will be cancelled according to law.